Longboard Pharmaceuticals Inc (LBPH)
20.66
+0.15
(+0.73%)
USD |
NASDAQ |
May 17, 16:00
20.66
0.00 (0.00%)
After-Hours: 20:00
Longboard Pharmaceuticals Shareholders Equity (Quarterly): 313.71M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 313.71M |
| December 31, 2023 | 40.92M |
| September 30, 2023 | 52.04M |
| June 30, 2023 | 58.11M |
| March 31, 2023 | 72.13M |
| December 31, 2022 | 61.47M |
| September 30, 2022 | 72.04M |
| Date | Value |
|---|---|
| June 30, 2022 | 82.97M |
| March 31, 2022 | 93.86M |
| December 31, 2021 | 103.32M |
| September 30, 2021 | 111.65M |
| June 30, 2021 | 117.45M |
| March 31, 2021 | 119.59M |
| December 31, 2020 | -2.692M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.692M
Minimum
Dec 2020
313.71M
Maximum
Mar 2024
92.61M
Average
77.55M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.66M |
| Total Liabilities (Quarterly) | 13.96M |